<DOC>
	<DOCNO>NCT00654329</DOCNO>
	<brief_summary>A randomize controlled clinical trial examine effect intranasal dexmedetomidine , Î±2-adrenorecptor agonist , pain control agitation child undergo BMT .</brief_summary>
	<brief_title>Dexmedetomidine v Fentanyl BMT</brief_title>
	<detailed_description />
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Subjects must meet follow inclusion criterion eligible participation : 1 . The subject 6 month 6 year age 2 . The subject 's American Society Anesthesiologists ( ASA ) physical status ASA 1 2 ( see appendix 1 ) 3 . The subject schedule elective bilateral myringotomy tube placement 4 . The subject 's parent/legally authorized guardian give write informed consent participate Subjects exclude study participation follow exclusion criterion exist : 1 . The subject history family ( parent sibling ) history malignant hyperthermia 2 . The subject know significant renal hepatic disorder determine medical history , physical examination laboratory test 3 . The subject know suspect allergy opioid analgesic dexmedetomidine 4 . The subject history . cardiovascular issue would preclude use dexmedetomidine , ( e.g . Down 's Syndrome , dysrhythmias , condition hypotension avoid ) 5 . The subject know central nervous system disease neurological impairment 6 . The subject ASA classification 3 great ( See Appendix 1 ) 7 . The subject medical condition require intravenous induction ( i.e . severe uncontrolled gastroesophageal reflux ) 8 . The subject refuse inhalation induction 9 . The subject schedule surgical subprocedure ( i.e . adenoidectomy , tonsillectomy )</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Dexmedetomidine , transmucosal , myringotomy ,</keyword>
</DOC>